---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-024431"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2026-01-27T23:59:59+00:00"
generated_at: "2026-05-16T07:23:15.123288+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Inovio extends Series A Warrant expiration to March 31, 2026

## Summary
- Amendment extends expiration of Series A Warrants (up to 13,564,268 shares) from Jan 28, 2026 to March 31, 2026.
- Warrants issued in July 2025 public offering; exercise price $1.75/share (pre-funded at $0.001).
- Original expiration was 30 days after FDA BLA acceptance for INO-3107; extension provides additional exercise window.
- All other warrant terms remain unchanged.

## SEC filing metadata
- accession: 0001193125-26-024431
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2026-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312526024431/0001193125-26-024431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312526024431/d63939d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-024431
- JSON: https://secwatch.observer/filing/0001193125-26-024431.json
- Plain text: https://secwatch.observer/filing/0001193125-26-024431.txt

## Key facts
- Material Agreements
  INOVIO PHARMACEUTICALS, INC. amended Series A Warrants (effective 2026-01-27).
  - Action: amendment
  - Effective: 2026-01-27
  source text: On January 27, 2026, Inovio Pharmaceuticals, Inc. (the “Company”) amended each of its outstanding Series A warrants issued on July 7, 2025 (the “Series A Warrants”) to extend the expiration date
  evidence_url: https://www.sec.gov/Archives/edgar/data/1055726/000119312526024431/0001193125-26-024431-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.